As immigration raids have swept the country, it’s not just immigrants who have been kidnapped and detained. American citizens have also been caught up in the Trump administration’s draconian policies.
As a Workday Architect and HR Technology Leader, Shivareddy Devarapalli is leading HR Digital Transformation at scale. Over the past ten years, Devarapalli has grown from a hands-on developer to a ...
WASHINGTON, Nov 20 (Reuters) - Salesforce said Thursday it is investigating “unusual activity” involving Gainsight-published applications that may have exposed customer data. In a brief statement, ...
LONDON, Oct 3 (Reuters) - Cybercriminals connected to a recent string of ransomware attacks on major British retailers said on Friday they had stolen almost 1 billion records from cloud technology ...
The Scattered Lapsus$ Hunters gang, which says it has stolen data from the Salesforce instances of dozens of international companies in recent months, upped its extortion game today by listing their ...
A sprawling coalition of hackers styling themselves as Scattered LAPSUS$ Hunters has claimed responsibility for one of the largest alleged data thefts in recent years, asserting that nearly one ...
From more than 30 target action dates in the last three months of the year, BioSpace has narrowed the list to six regulatory decisions that could have far-reaching implications for biopharma and ...
1. Erasmus MC Center of Expertise for Inherited Cardiovascular Diseases, Rotterdam, the Netherlands 2. Centre for Heart Muscle Disease, University College London (UCL), UK 3. Inherited Cardiovascular ...
Personal Data Servers are the persistent data stores of the Bluesky network. It houses a user's data, stores credentials, and if a user is kicked off the Bluesky network the Personal Data Server admin ...
Workday Rising 2025 opens with announcements of new AI agents for HCM and finance, but the big news is the new Workday Build developer platform and Data Cloud, along with consumption-based pricing.
MAPLE-HCM establishes Cytokinetics, Incorporated's aficamten as superior to metoprolol in obstructive HCM, reframing it as a potential first-line, best-in-class therapy. Commercial potential is ...
During a medical event on Saturday, Cytokinetics (NASDAQ:CYTK) announced primary results from its Phase 3 MAPLE-HCM trial for lead asset aficamten in symptomatic obstructive hypertrophic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback